Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100914Source: DataRank Database

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes is a research paper published in JTO Clinical and Research Reports (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: goldTopics (14)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Caressa Hui ORCID,Joel W. Neal ORCID,Seema Nagpal ORCID,Mohana Roy ORCID,Millie Das ORCID

Live enrichment

PubMed:41256965 PMC:PMC12621429 OpenAlex:https://openalex.org/W4414806203

National Institutes of Health National Cancer Institute

Grant: K12CA138464

National Institutes of Health

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jtocrr.2025.100914

publisherhttps://doi.org/10.1016/j.jtocrr.2025.100914

publisherhttps://api.elsevier.com/content/article/PII:S2666364325001328?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666364325001328?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41256965

Fields of Study

Lung Cancer Treatments and MutationsBrain Metastases and TreatmentLung Cancer Research Studies

Keywords

Central nervous systemTyrosine kinaseTyrosine-kinase inhibitorChemotherapyTumor progressionCentral nervous system diseaseTargeted TherapyLeptomeningeal DiseaseIntracranial MetastasesAlk-rearranged NsclcCentral Nervous System Progression

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

FAIR Checklist

Authors (11)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)